PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 8369380

Random-effects models, for longitudinal data using Gibbs sampling.

W R Gilks·C C Wang·B Yvonnet·P Coursaget
View original source ↗Export metadata ↓

Abstract

Analysis of longitudinal studies is often complicated through differences amongst individuals in the number and spacing of observations. Laird and Ware (1982, Biometrics 38, 963-974) proposed a linear random-effects model to deal with this problem. We propose a generalisation of this model to accommodate multiple random effects, and show how Gibbs sampling can be used to estimate it. We illustrate the methodology with an analysis of long-term response to hepatitis B vaccination, and demonstrate that the methodology can be easily and effectively extended to deal with censoring in the dependent variable.

Explore related subjects

Follow-Up StudiesHepatitis BHepatitis B Surface AntigensHepatitis B VaccinesHumansImmunizationImmunization, SecondaryInfantLongitudinal StudiesMathematicsModels, StatisticalMultivariate AnalysisJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W R Gilks, C C Wang, B Yvonnet, P Coursaget. 1993. Random-effects models, for longitudinal data using Gibbs sampling.. https://pubmed.ncbi.nlm.nih.gov/8369380/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1998

[Radiotherapy alone in early stages of low malignancy non-Hodgkin lymphomas].

About 25% of patients with low grade Non-Hodgkin's Lymphomas (NHL) of the B-cell type present in an early stage. They are candidates for radiotherapy alone. Thereby a complete remission can be achieved in the majority of stage I and II patients with centroblastic-centrocytic (cb-cc), centrocytic (cc) and immunocytic (ic) NHL--at least in cb-cc also a relapse-free survival of 50-60%. Standardization of the radiotherapeutic technique is essential to reduce the risk of recurrence. Retrospective analyses of radiotherapeutic studies from the literature are limited by the lack of homogenous irradiation techniques. Relapses occur inside as well outside of radiotherapy ports. It is the aim of current studies to optimize the radiotherapeutic approach with curative intent.

Follow-Up Studies↗
PubMed1998

[New therapeutic possibilities in pulmonary emphysema. Conservative therapy--surgical lung volume reduction--lung transplantation].

The spectrum of therapeutic possibilities in pulmonary emphysema has recently been expanded by surgical lung volume reduction. Improvements in surgical technique have now lowered the mortality rate of the procedure to less than 5%, thus providing a chance of prolonging survival and improving the quality of life of severely ill patients in need of oxygen. To date, experience has been gained with this procedure in several thousands of patients in the U.S.A. and Europe, some groups of patients have now been followed up for about three years. The procedure is not recommended for use in patients with genetically determined alpha 1-antitrypsin deficiency. Surgical bullectomy is practiced when individual bullae affect more than 50% of a lung. In special cases, the possibility of lung transplantation should also be considered. In addition to the invasive approaches, survival, but in particular quality of life, can also be improved by conservative procedures. These include medical anti-obstructive treatment, the early use of antibiotics in the case of infections, but also physiotherapeutic measures such as pursed-lip breathing and exercises to strengthen diaphragma. Palliative measures in advanced stages are long-term oxygen therapy and in special cases non-invasive self-ventilation.

Follow-Up Studies↗